Literature DB >> 29129773

Gambogic acid ameliorates diabetes-induced proliferative retinopathy through inhibition of the HIF-1α/VEGF expression via targeting PI3K/AKT pathway.

Jianyi Cui1, Rui Gong2, Shuiqing Hu2, Ling Cai2, Lei Chen3.   

Abstract

AIMS: Gambogic acid (GA) is one of active components of Chinese medicine gamboges resin. Diabetic retinopathy (DR) is a most serious microvascular complication of diabetes and also the leading cause of blindness. The aim of this study is to evaluate the beneficial effect of GA on diabetes-induced retinal angiogenesis and further explore the potential mechanisms.
MATERIAL AND METHODS: High glucose (HG)-treated RF/6A cells and STZ-induced diabetic mice were used as in vitro and in vivo models. Then the effects of GA on proliferation, migration and tube formation in RF/6A cells and pathomorphological changes in STZ-induced diabetic mice were determined. The activation of HIF-1α/VEGF and PI3K/AKT signaling pathways was assessed by various molecular biological experiments. KEY
FINDINGS: According to our results, GA inhibited HG-induced proliferation, migration and tube formation in choroid-retinal endothelial RF/6A cells. The upregulation of HIF-1α and VEGF induced by HG in RF/6A cells was restrained by GA treatment significantly. Moreover, GA suppressed retinal pathomorphological changes and angiogenesis in STZ-induced diabetic mice in vivo, and also inhibited the activation of HIF-1α/VEGF pathway induced by diabetics. Finally, GA suppressed the activation of PI3K/AKT signaling pathway in STZ-induced diabetic mice in vivo and in HG-induced RF/6A cells in vitro. Further activation of PI3K/AKT pathway by IGF-1 restrained the beneficial effect of GA in RF/6A cells. SIGNIFICANCE: Our results provide evidence that GA may ameliorate diabetes-induced retinal angiogenesis, which are proofs that GA may be developed as a potential drug for treating DR.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Diabetic retinopathy; Gambogic acid; HIF-1α; PI3K/AKT; VEGF

Mesh:

Substances:

Year:  2017        PMID: 29129773     DOI: 10.1016/j.lfs.2017.11.007

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

Review 1.  Antidiabetic Potential of Medicinal Plants and Their Active Components.

Authors:  Bahare Salehi; Athar Ata; Nanjangud V Anil Kumar; Farukh Sharopov; Karina Ramírez-Alarcón; Ana Ruiz-Ortega; Seyed Abdulmajid Ayatollahi; Patrick Valere Tsouh Fokou; Farzad Kobarfard; Zainul Amiruddin Zakaria; Marcello Iriti; Yasaman Taheri; Miquel Martorell; Antoni Sureda; William N Setzer; Alessandra Durazzo; Massimo Lucarini; Antonello Santini; Raffaele Capasso; Elise Adrian Ostrander; Muhammad Iqbal Choudhary; William C Cho; Javad Sharifi-Rad
Journal:  Biomolecules       Date:  2019-09-30

2.  To Explore the Pathogenesis of Vascular Lesion of Type 2 Diabetes Mellitus Based on the PI3K/Akt Signaling Pathway.

Authors:  Jia-Rong Gao; Xiu-Juan Qin; Zhao-Hui Fang; Li-Ping Han; Ming-Fei Guo; Nan-Nan Jiang
Journal:  J Diabetes Res       Date:  2019-04-17       Impact factor: 4.011

3.  Alterations in the polysialylated neural cell adhesion molecule and retinal ganglion cell density in mice with diabetic retinopathy.

Authors:  Natalia Lobanovskaya; Monika Jürgenson; Anu Aonurm-Helm; Alexander Zharkovsky
Journal:  Int J Ophthalmol       Date:  2018-10-18       Impact factor: 1.779

4.  Ginsenoside Re Attenuates High Glucose-Induced RF/6A Injury via Regulating PI3K/AKT Inhibited HIF-1α/VEGF Signaling Pathway.

Authors:  Weijie Xie; Ping Zhou; Muwen Qu; Ziru Dai; Xuelian Zhang; Chenyang Zhang; Xi Dong; Guibo Sun; Xiaobo Sun
Journal:  Front Pharmacol       Date:  2020-05-21       Impact factor: 5.810

5.  Investigating the Mechanisms of Pollen Typhae in the Treatment of Diabetic Retinopathy Based on Network Pharmacology and Molecular Docking.

Authors:  Rongrong Zhou; Yuqing Zhang; Liyun Duan; Yuehong Zhang; Yingying Duan; Xiaomin Kang; Fengmei Lian
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-03       Impact factor: 2.629

6.  A Mechanistic Exploratory Study on the Therapeutic Efficacy of Astragaloside IV Against Diabetic Retinopathy Revealed by Network Pharmacology.

Authors:  Zhi-Hao Zhao; Min Xu; Cong Fu; Ying Huang; Ting-Hua Wang; Zhong-Fu Zuo; Xue-Zheng Liu
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

7.  Gambogic acid ameliorates high glucose- and palmitic acid-induced inflammatory response in ARPE-19 cells via activating Nrf2 signaling pathway: ex vivo.

Authors:  Jun Chen; Lihua Li; Yun Zhou; Jiahua Zhang; Lei Chen
Journal:  Cell Stress Chaperones       Date:  2020-11-27       Impact factor: 3.667

8.  Cinobufagin suppresses colorectal cancer angiogenesis by disrupting the endothelial mammalian target of rapamycin/hypoxia-inducible factor 1α axis.

Authors:  Xiaowu Li; Chunhui Chen; Yu Dai; Chengzhi Huang; Qinrui Han; Linlin Jing; Ye Ma; Yihua Xu; Yawei Liu; Liang Zhao; Junjiang Wang; Xuegang Sun; Xueqing Yao
Journal:  Cancer Sci       Date:  2019-03-29       Impact factor: 6.716

9.  Activation of the sweet taste receptor T1R3 by sucralose attenuates VEGF-induced vasculogenesis in a cell model of the retinal microvascular endothelium.

Authors:  Polina Lizunkova; Emmanuella Enuwosa; Havovi Chichger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-10-23       Impact factor: 3.117

10.  Spalt-Like Protein 4 (SALL4) Promotes Angiogenesis by Activating Vascular Endothelial Growth Factor A (VEGFA) Signaling.

Authors:  Jinbo Sun; Zhining Zhao; Wei Zhang; Qisheng Tang; Fan Yang; Xiangnan Hu; Chong Liu; Bin Song; Bo Zhang; He Wang
Journal:  Med Sci Monit       Date:  2020-03-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.